Inventor
VAN KAMPEN MARJA
DE29 patents
⚠️ This page may combine multiple inventors who share the name “VAN KAMPEN MARJA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HENDRIX MARTIN
7 patentsUS8158633B2Apr 17, 2012
Phenyl-substituted pyrazolopyrimidines
HENDRIX MARTIN59 citations97
US8076355B2Dec 13, 2011
2-heteroarylcarboxylic acid amides
HENDRIX MARTIN13 citations82
US8884017B2Nov 11, 2014
2-heteroarylcarboxylic acid amides
HENDRIX MARTIN0 citations51
US8822479B2Sep 2, 2014
6-cyclylmethyl-and 6-alkylmethyl-substituted pyrazolepyrimidines
HENDRIX MARTIN0 citations51
US8741907B2Jun 3, 2014
Alkyl-substituted pyrazolopyrimidines
HENDRIX MARTIN0 citations51
US8642605B2Feb 4, 2014
6-cyclylmethyl-and 6-alkylmethyl-substituted pyrazolepyrimidines
HENDRIX MARTIN0 citations51
US8809348B2Aug 19, 2014
6-arylmethyl substituted pyrazolo[3,4-d]pyrimidines
HENDRIX MARTIN1 citations48
BAYER IP GMBH
6 patentsUS10214524B2Feb 26, 2019
2-heteroaryl carboxamides
BAYER IP GMBH1 citations62
US9914729B2Mar 13, 2018
Amides of acetic and propionic acids
BAYER IP GMBH1 citations62
US9714242B2Jul 25, 2017
Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists
BAYER IP GMBH1 citations62
US9067931B2Jun 30, 2015
2-heteroaryl carboxamides
BAYER IP GMBH2 citations62
US10414762B2Sep 17, 2019
Amides of acetic and propionic acids
BAYER IP GMBH0 citations51
US10196388B2Feb 5, 2019
Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists
BAYER IP GMBH0 citations51
BOEHRINGER INGELHEIM INT
5 patentsUS8039477B2Oct 18, 2011
Substituted pyrazolo[3,4-d]pyrimidin-4-one compounds as phosphodiesterase inhibitors
BOEHRINGER INGELHEIM INT63 citations96
US7737156B2Jun 15, 2010
Selective phosphodiesterase 9A inhibitors as medicaments for improving cognitive processes
BOEHRINGER INGELHEIM INT27 citations92
US7615558B2Nov 10, 2009
6-arylmethylprazolo[3,4-d]pyrimidines
BOEHRINGER INGELHEIM INT31 citations92
US7488733B2Feb 10, 2009
6-arylamino-5-cyano-4-pyrimidinones as pde9a inhibitors
BOEHRINGER INGELHEIM INT37 citations92
US8044060B2Oct 25, 2011
6-cyclylmethyl- and 6-alkylmethyl pyrazolo[3,4-D]pyrimidines, methods for their preparation and methods for their use to treat impairments of perception, concentration learning and/or memory
BOEHRINGER INGELHEIM INT11 citations84
BAYER SCHERING PHARMA AG
3 patentsUS7795453B2Sep 14, 2010
Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists
BAYER SCHERING PHARMA AG19 citations91
US7732477B2Jun 8, 2010
2-heteroarylcarboxylic acid amides
BAYER SCHERING PHARMA AG22 citations91
US7977485B2Jul 12, 2011
2-heteroaryl carboxamides
BAYER SCHERING PHARMA AG3 citations61
BAYER HEALTHCARE AG
3 patentsUS7247728B2Jul 24, 2007
Bicyclic N-arylamides
BAYER HEALTHCARE AG9 citations73
US7138410B2Nov 21, 2006
Aza-bicyclic N-biarylamides with affinity for the α7 nicotinic acetylcholine receptor
BAYER HEALTHCARE AG9 citations73
US7553851B2Jun 30, 2009
Amides of acetic and propionic acids
BAYER HEALTHCARE AG6 citations72